EARLY-STAGE ER+ BREAST CANCER
Clinical trials for EARLY-STAGE ER+ BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY-STAGE ER+ BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY-STAGE ER+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can we wake and kill sleeping breast cancer cells? new trial aims to find out
Disease control Recruiting nowThis study is for people with early-stage ER+ breast cancer who still have hidden cancer cells in their bone marrow after surgery and standard therapy. It tests whether adding drugs like hydroxychloroquine or avelumab, with or without palbociclib, can clear those leftover cells a…
Matched conditions: EARLY-STAGE ER+ BREAST CANCER
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a single dose of radiation before surgery replace weeks of treatment?
Disease control Recruiting nowThis study tests a new way to treat early-stage ER+ breast cancer using a single, strong dose of radiation before surgery. It also explores using a special ultrasound with microbubbles to check lymph nodes without a surgical biopsy. The goal is to see if this approach can elimina…
Matched conditions: EARLY-STAGE ER+ BREAST CANCER
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC